로딩 중…
지수 로딩 중…
Twist Bioscience Corporation
TWST· NASDAQ· Health Care· Health Care Equipment & Services
$128.94-15.60%
2026-11-02
Financials
Valuation Metrics
Twist Bioscience Corporation's Market Cap is $8.03B. At end of 2025 it was $1.94B. Ranked #934 of 3,118 in US market (top 30%), #295 of 1,474 on NASDAQ (top 20%), #69 of 203 in Health Care Equipment & Services (top 34%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $8.03B | US#934/3,118 Sec#69/203 |
| Revenue | $432M | US#2,302/3,118 Sec#145/203 |
| Net Income | $-137M | US—/3,118 Sec—/203 |
| Total Assets | $672M | US#2,645/3,118 Sec#147/203 |
| Net Assets | $446M | US#2,294/3,118 Sec#122/203 |
| Value | ||
| P/B | 18.01x | US#2,796/3,118 Sec#181/203 |
| P/S | 18.59x | US#2,862/3,118 Sec#200/203 |
| FCF Yield | -1.16% | US—/3,118 Sec—/203 |
| Profitability | ||
| ROE | -30.67% | US#2,564/3,118 Sec#157/203 |
| ROA | -20.33% | US#2,791/3,118 Sec#180/203 |
| Op. Margin | -31.91% | US#2,616/3,118 Sec#171/203 |
| Revenue Growth | 19.19% | US#723/3,118 Sec#47/203 |
| Financial Health | ||
| Debt Ratio | 50.86% | US#578/3,118 Sec#65/203 |
| Total Debt | $94M | US#2,446/3,118 Sec#139/203 |
| FCF | $-93M | US#2,620/3,118 Sec#188/203 |
| Cash | $117M | US#2,111/3,118 Sec#131/203 |
| Current Ratio | 2.67x | US#886/3,118 Sec#91/203 |
| Performance | ||
| 1Y Return | 292.03% | US#9/3,118 Sec#3/203 |
| 1M Return | -31.66% | US#2,818/3,118 Sec#189/203 |
| From 52W High | -41.31% | US#1,961/3,118 Sec#150/203 |
| 1Y MDD | -37.10% | US#1,657/3,118 Sec#98/203 |
| Trading | ||
| Volume | 2,438,620 shares | US#629/3,118 Sec#30/203 |
| Trading Value | $334M | US#235/3,118 Sec#20/203 |
| Per Share | ||
| EPS | $-2.20 | US—/3,118 Sec—/203 |
| BPS | $7.16 | US#2,068/3,118 Sec#124/203 |